Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Boehringer Ingelheim
Harvard Business School
Baxter
McKesson

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drug Price Trends for FLUVOXAMINE MALEATE

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for FLUVOXAMINE MALEATE

Average Pharmacy Cost for FLUVOXAMINE MALEATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
FLUVOXAMINE MALEATE 50 MG TAB 68084-0837-95 0.43505 EACH 2019-09-18
FLUVOXAMINE MALEATE 100 MG TAB 00185-0157-01 0.40991 EACH 2019-09-18
FLUVOXAMINE MALEATE 100 MG TAB 00378-0414-01 0.40991 EACH 2019-09-18
FLUVOXAMINE MALEATE 100 MG TAB 51079-0993-01 0.40991 EACH 2019-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for FLUVOXAMINE MALEATE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
FLUVOXAMINE MALEATE 25MG TAB AvKare, Inc. 60505-0164-01 100 47.74 0.47740 EACH 2019-09-06 - 2022-12-31 FSS
FLUVOXAMINE MALEATE 50MG TAB AvKare, Inc. 60505-0165-01 100 52.51 0.52510 EACH 2019-09-06 - 2022-12-31 FSS
FLUVOXAMINE MALEATE 100MG TAB AvKare, Inc. 60505-0166-01 100 57.29 0.57290 EACH 2019-09-06 - 2022-12-31 FSS
FLUVOXAMINE MALEATE 50MG TAB 10X10 Mylan Institutional, Inc. 51079-0992-20 100UD 40.46 0.40460 EACH 2017-11-15 - 2022-09-29 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
McKinsey
Dow
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.